chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a 15 month old female with no pertinent medical history and no drug reactions/allergies who on 07-Aug-2007 was vaccinated SC with a 0.5 mL dose of PROQUAD (lot number: 0478U).  Concomitant therapy included PREVNAR.  On 16-Nov-2007 the patient was seen in the office for a rash.  On 17-Nov-2007 the patient was seen again in the office because the rash had gotten worse.  The physician diagnosed the rash as shingles.  The rash developed on the patient's back, right buttock, and genital area.  There were no complications.  The patient was put on acyclovir therapy.  No further information was available.  Unspecified medical attention was sought.  No lab diagnostics studies were performed.  The outcome was reported as recovering.  There was no product quality complaint.  Additional information has been requested. Information has been received froma registered nurse concerning a 15 month old female with no pertinent medical history and no drug reactions/allergies who on 07-AUG-2007 was vaccinated SC in the right thigh with a second 0.5 mL dose of MMR (Oka/Merck upgrade process) (lot number: 657032/04780). On 16-NOV-2007 the patient was seen in the office for a rash on her back and legs. The rash was lcoated on th elower back and genitalia. The rash was blister-like and raised. The rash was vesicular locatted on the lower back and right vulva. Her temperature that day was 97.6 F tympanic. On 17-NOV-2007 the patient was seen again in the office because the rash had gotten worse. The physician diagnosed the rash as shingles. The rash developed on the patient's back, right buttock, and genital area. There were no complications. The patient was pit on acyclovir therapy.Unspecified medical attention was sought. No lab diagnostics studies were performed. The outcome was reported as recovering. There was no product quality complaint. Follow up information indicated that on 08-NOV-2007 the patient was vaccinated in the right arm at 9:00 am with a third dose of HEPATITIS B vaccine (lot number 657180/0224U). The outcome was reported as recovered. No additional information is expected.
A report has been received from a Health Professional concerning a child, male subject, who had been receiving QLAIV (intranasal), 1 dose. Concomitant medications included flu shot. FLUMIST QUADRIVALENT started on 27-Nov-2014. The reporter who dispensed in a clinic setting the FLUMIST vaccine to the wrong patient population (under 2 years of age). The outcome of the event of wrongful administration is unknown. The report was considered to be non-serious. The reporter considered that there was no causal relationship between wrongful administration and QLAIV.
Left arm swollen, red, warm, and itchy at site of injection. Treated with oral Benadryl and ice to site.
Post vaccine pt became lightheaded and clammy. Pt transferred to med obs via wc. Pt reported feeling better after sitting on stretcher. Vitals obtained and monitored. Pt released at 12:51 PM. Vitals as follows: 1205 LYING BP 138/90 HR 77 RR 16 SpO2 100% 1210 SITTING BP 138/87 HR 72 RR 16 SpO2 100% 1215 SITTING BP 130/86 HR 70 RR 16 SpO2 100% 1245 SITTING BP 134/84 HR 69 RR 16 SpO2 100% 1250 STANDING BP 132/93 HR 71 RR 16 SpO2 100%
Patient had blistering, swelling, redness, itchiness and pain at injection site.
Information has been received from a registered nurse concerning a female patient who on an unspecified date was vaccinated with a dose of PNEUMOVAX.  The nurse reported that the patient experienced swelling at the injection site, high fever, extreme pain and rash down her arm after getting PNEUMOVAX.  Subsequently, the patient recovered.  This is one of two reports received from the same source.  Additional information has been requested.
12  hours after shot Headache, stomach upset, fever 100.6, body aches x 36 hours
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 13Oct2021 at 12:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 51 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Syringomyelia" (unspecified if ongoing); "Known allergies: Iodine" (unspecified if ongoing), notes: Known allergies: Iodine. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: Treatment of COVID-19; (15Jan2022) Positive, notes: on day 3, I started coughing, choking and retest positive for Covid. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical Course: Anti-viral details: The patient has received treatment for COVID-19 with Paxlovid from 13Jan2022 to 17May2022. Adverse event: I took paxlovid and on day 1 and day 2 I saw good improvement, breathing and coughing improve but on day 3, I started coughing, choking and retest positive for COViD , then after completing day five I lost all abilities to swallow. I required a pick line, for nutrition and several hospitalizations including ICU. They diagnosed me with Guillian Barre. AE resulted in: Hospitalization, Prolongation of existing hospitalization (treatment received during existing hospitalization), Life threatening illness (immediate risk of death from the event), Disability or permanent damage.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Total body weakness, especially in thigh muscles, severe headaches bursting pain lasting 10 seconds or so. Muscle cramping and overall pain especially in lower back. Symptoms started to relieve after 2 weeks, low back and hip pain still remains. I have had through my primary Dr. physical therapy, MRI, Xray, Chiropractic Dr. a Neurologiy Dr and Pain Managment Dr. It has been over 4 weeks now. I am on medications and steriods now.
Received vaccines 10/04/04. Initially with a small pimple left thigh thigh night. Then 1 night later, larger erythematous, felt warm and hard. Seen by MD on 10/6/4. 2cm erythematous, indurated area left anterior thigh.
I had a miscarriage on Sept. 10th. I went in for a baby ultra sound and their was no heart beat. I had to get an D&C done. On Jan 20th, I tested positive for Covid-19. I had fever, chills, cough, headache, body aches, congestive, and sore throat. I also had some stomach ache with nausea. These symptoms lasted for about 5 days. I still have the coughing and congestive.
chills; fell; headache; his was balance off; throat hurt; sinuses were running; lightheaded/dizziness; loss of taste; cough; This is a spontaneous report from a contactable consumer (Consumer himself). A 64-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unknown route injected in the left arm on 04Feb2021 (Batch/Lot Number: EL3249) (age at vaccination 64-year-old) as dose 1, single for COVID-19 immunisation. The patient medical history included diabetes and blood pressure high since years ago. The patient concomitant medications were not reported. The patient experienced cough on 04Feb2021, loss of taste, lightheaded/dizziness, throat hurt, sinuses were running on 05Feb2021, chills, headache, balance was off, coughed so hard he blacked out and fell down. The laboratory investigation which included temperature was low grade, 96.6 degrees Fahrenheit on 04Feb2021. The patient stated he got the first dose of the Pfizer COVID-19 vaccine last Thursday. He says when he got home afterwards he started coughing, and the next morning when he woke up he couldn't taste anything and was lightheaded. He says his throat hurt and his sinuses were running, and he was coughing up phlegm. He says his balance was off, and a couple times he coughed so hard that he blacked out and fell down. He says he thinks maybe he had the virus before he got the shot. He says he doesn't know, he is supposed to get bloodwork soon and maybe he shouldn't be around those people if he has COVID. He says he asked his doctor, who told him to call Pfizer. AE Treatment was he has been taking something like the Vicks things you put up in your nose, called Benzedrex. He says that the LOT for this product looks like 835 with a weird c with something else in it, EXP Aug2022. He says he sticks it up his nose and breathes, it is mentholated. He says he has also been gargling salt water and putting saline in his nostrils, and using an oral rinse that his doctor gave him when he had a tooth pulled 6 months ago called Peridex chlorhexidine, he thinks that is the name brand. LOT 473XTTRI, he says that there is no EXP on there, it says 0.12% clarified to 1.2% rinse. He says he doesn't see a NDC, he does see a UPC that starts with a small 3, then is 011620016, then has a small 5 past it. He says that the rinse is probably bad, but it helped. He says he had no injuries after he blacked out and fell. The patient received treatment for cough, throat hurt and did not received treatment to other events. The outcome of the events was unknown.  Follow-up attempts completed. No further information expected.
After receiving the 1st dose Moderna vaccine rec'd on 3/3 at 10am and by 1pm I had a headache, I got chills, then that evening I had an acid stomach, and on 3/4 I had little tiny blisters around my lips and as time passed it spread  and popped up a few times on the end of my nose. Today I just received the 2nd dose today 4/1 and hoping these blisters will not return.
Facial twitch on left side of face; This is a spontaneous report from a contactable pharmacist, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EV00181) via an unspecified route of administration in the right arm on 21Jun2021 at 14:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer (triple negative). The patient had no known allergies to food, medications, or other products. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Jun2021 at 15:00, the patient experienced facial twitch on left side of face. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event facial twitch on left side of face was resolved on an unknown date in 2021.
Was in Maine on vacation early July - immunization 6/14/10 - red rash in trigeminal area of (R) cheek wrapped around ear 7/17; 7/18 moved to mild or vital line in Trigeminal area; palsy of lids, cheek, perioral developed 7/19 (couldn't smile on (R) side) - persists 7/20/10 ER visits 7/17 & 7/18 office 7/20/10.
headache on left side of head which was similar to migraine; This is a spontaneous report from a contactable other healthcare professional reported for herself. A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EJ1685, expiry date unknown) intramuscular on left arm on 19Dec2020 11:30 at single dose for COVID-19 immunization. Medical history included penicillin allergies, allergies to sulfa drugs and allergies to cephalosporins. Concomitant medication included vitamin D3 and amylase, ascorbic acid, cellulase, folic acid, lipase, protease nos (JUICE PLUS); both from unspecified date for unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 19Dec2020 13:00, the patient experienced headache on left side of head which was similar to migraine and went away on Dec2020 by taking 2 Aleve. The event was considered non-serious and did not results in death, not life threatening, did not caused/prolonged hospitalization, not disabling/incapacitating, not a congenital anomaly/birth defect.
LARGE, red, hot to the touch, swollen area on my child's thigh around the injection site.  She says it's painful to the touch.  I did not notice this reaction yesterday or on the day the vaccine was given.
Nurse squeezed upper arm extremely hard before administering shot, have had pain in upper arm since day after receiving shot, have difficulty raising my left arm and moving it to the left, experience pain nightly before falling to sleep, take TYLNEOL during the day and one ADVIL PM at night.
Patient received COVID-19 vaccination at 11:15am on 1/29. At this time (02:30pm), patient reports skin pruritis mainly on abdomen. On exam, pinpoint mild erythematous papules located on lower abdomen.  Patient denies: throat pain, difficulty swallowing, shortness of breath, edema  Responded to 50mg Benadryl. No further medications needed.
22 days after the second shot my feet swelled and itched and were reddened for 4 days. it was worse at night.
ill for a day; fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (ill for a day), PYREXIA (fever) and FATIGUE (fatigue) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M21A and 015C21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: STEROIDS in 2019. Concurrent medical conditions included COPD.   On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (ill for a day), PYREXIA (fever) and FATIGUE (fatigue). At the time of the report, ILLNESS (ill for a day), PYREXIA (fever) and FATIGUE (fatigue) had resolved.            No concurrent medication was reported by patient.  No treatment medication was reported by patient.   This case was linked to MOD-2021-294246 (Patient Link).
Swelling in left ring finger w/ rash. Swelling and pain through left arm. Lightheadedness, swelling sensation in tongue/throat. Tingling and numbness in left hand. Pain in hand. Steroid/antihistamine/ibuprofen/sleep aid.
COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18Mar2021 as dose 1, single (Lot number: ER2613), in left arm, on 05Apr2021 as dose 2, single (Lot number: EW0151), in left arm and on 14Jan2022 as dose 3, (booster), single (Lot number: FF2590) at the age of 62 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "prediabetic" (unspecified if ongoing), notes: prediabetic, no meds/acute bronchitis (breathing treatment at the hospital on 28Jun2022); "acute bronchitis" (unspecified if ongoing), notes: prediabetic, no meds/acute bronchitis (breathing treatment at the hospital on 28Jun2022). Concomitant medication(s) included: LISINOPRIL AND HYDROCHLOROTHIAZIDE, start date: Jan2014; ATORVASTATIN, start date: Jan2020; METHYLPREDNISOLONE, start date: 28Jun2022, stop date: 03Jul2022. Past drug history included: Demerol, reaction(s): "Drug allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of drug ineffective, covid-19.
He had his first dose of Pfizer. He signed up for a Moderna booster. After he got the Moderna booster the alerted the pharmacist that he only got the first dose of Pfizer. The pharmacist then gave him a additional Moderna booster to make the two shots equal the same amount as a second Moderna shot.
had "faint-like" episode immediately p/vax & was really tired for about 45min, then recovered. Devel fine rash on face the next day, 28Apr;
I was diagnose positive for Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I was diagnose positive for Covid-19) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Sep-2021, the patient experienced COVID-19 (I was diagnose positive for Covid-19). At the time of the report, COVID-19 (I was diagnose positive for Covid-19) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.; Sender's Comments: This case concerns a 49-year-old male patient with no relevant medical history reported who experienced  non serious unexpected event of COVID-19. The event occurred approximately 5 days after the first dose of Spikevax. Rechallenge was unknown since no information regarding the second dose was disclosed. The benefit-risk relationship of drug is not affected by this report
A physician via a sales representative reported that the physician had a pt whose child received Rota Shield and developed a fever of 104 deg F and experienced floppiness. As of the date of this report, the pt still has "some floppiness." The reporter considered these events medically important. As of the date of this report, no further info was available. Follow-up info received 7/26/02 further describes the adverse events; identifies vaccines given within four weeks included the pt's date of birth, gender, name and address. A physician reported htat a 3 month old female receive her first dose of Rota Shield on 1/6/99 and five days later develped a fever of 104 deg F and experienced floppiness. As of 6/4/02, she continued ot have "some" floppiness. As of 7/9/02, the pt still had "some" gross and fine motor delays. She has been referred to "Early Intervention." Info has been forwarded to manufacturer of Tripedia and IPV. The reporter considered these events medically important (OMIC).
I started having symptoms on 09/20/2021. I am a freshman in college and I started experiencing some like Covid 19 symptoms. Some people were having the same symptoms and they tested negative for Covid. 4 days after I lost my smell and taste. I went to urgent care and got tested for Covid and it came back positive. I did not have a fever but I had a really bad cough, a lot of pressure in my head, stuffy nose, a lot of headaches. About a week and a half later I got the monoclonal infusion treatment. After that everything started to clear out. I have diminished lung capacity. I can definitely tell I cannot breathe as well.
patient received flu vaccine at approximately 2pm.  She "jumped" off the table and left with her dad. Dad called the office at around 240pm to report that after they left the office and got on the elevator, pt reported "feeling light-headed and having stomach pains like she had period cramps".  During this call, dad reported the patient was feeling better. It was advised that dad monitor the patient and injection site. dad was agreeable to the plan.  Later that night, around 8pm, dad called out after hours service and got the on-call doctor, Dr. dad reported a fever of 103 and pain to back of head. Denied neck pain and had full ROM without pain to neck. no photophobia and some mild abnominal pain and dizziness. She has not had any known contact with anyone who was sick.
This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's historical condition, concomitant medications and drug reactions or allergies were not reported. On 04-SEP-2018, the patient was vaccinated with a improperly stored dose of LIQUID PEDVAXHIB for prophylaxis (which had a lot # of N012119 and an expiration date 06-FEB-2020 however, route, dosage schedule, anatomical location and dosage number were not reported), The LIQUID PEDVAXHIB was exposed to a temperature between 9 degrees Celsius(C) to 25 degrees C for time frame of 48 minutes.
she felt very fatigued with a headache; she felt very fatigued with a headache; neck and shoulder pain; neck and shoulder pain; mild dizziness; This is a spontaneous report from a contactable consumer reporting for self. This female patient with unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route of administration on 30Dec2020 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient stated that she received the first dose of vaccine on 30Dec2020 and the next day (31Dec2020) she felt very fatigued with a headache, neck and shoulder pain, and then experienced mild dizziness. Today (11Jan2021) is the first day that she feels better. She was scheduled to receive the second dose of the vaccine on 20Jan2021 and she wanted to know if she should get the second dose considering her reaction after the first dose. She stated that she used ibuprofen (ADVIL) for the headache and it only helped for about an hour and then she drank Theraflu hot tea and that helped her the most. The outcome of events was recovering.   Information on the lot/batch number has been requested.
I started feeling some neck pain for three tests so I went to urgent care and a blood test showed a high white blood count a few days later leukemia was diagnosed. I have started Chemotherapy for eight months and treatments at home and this is the current standing.
This spontaneous report as received from a pharmacist via public representative refers to unknown number of patients of unknown demographics. On an unknown date the patients were vaccinated with ZOSTAVAX (dose, route, lot, expiry date unknown). Pharmacist stated that most of his patients had injection site soreness and redness after the vaccination with ZOSTAVAX. The outcome of the events injection site soreness and redness after vaccination was unknown. Additional information has been requested.
numbness and tingling on left side of head, face, left arm and left leg and dizzy.
quarter sized red, swollen spot at injection site started 5 days post-admin; by 10 days spot was "baseball sized" per pt. only painful to touch. pt treating with tylenol, claritin, and benadryl